Medical News

RSS

Two community health centers receive GE grant to provide increased access to healthcare in the US

The GE Foundation - the philanthropic organization of GE - announced today the award of $500,000 to two Erie-based community health centers in an effort to help increase access to quality healthcare across the United States.

9 Feb 2011

FDA clears EOS orthopedic imaging system for use in lower limbs applications

EOS imaging announced today that it has received FDA clearance of its sterEOS 3D orthopedic imaging workstation for use in lower limbs applications for patients 15 years and older.

9 Feb 2011

Humana Military introduces new website for mobile phones and tablets

Humana Military Healthcare Services, a wholly-owned subsidiary of Humana Inc., announces the launch of the mobile Humana Military website for mobile phones and tablets.

9 Feb 2011

Targacept initiates TC-6987 Phase 2 study in patients with asthma, Type 2 diabetes

Targacept, Inc., a clinical-stage biopharmaceutical company developing novel NNR Therapeutics™, today announced the initiation of separate Phase 2 clinical studies of its product candidate TC-6987 in disorders characterized by inflammation, one in asthma and one in Type 2 diabetes.

9 Feb 2011

Mobily introduces first mobile medical imaging service

Saudi Arabian telecommunications company Mobily and Great Connection Inc., creator of the innovative Mobile Baby service, announced the launch of the first mobile medical imaging service that enables ultrasound stills, 3D images and video clips to be sent directly from an ultrasound machine to a mobile device.

9 Feb 2011

Evotec signs definitive agreement to acquire all shares in Kinaxo

Evotec AG today announced the signing of a definitive agreement to acquire all shares in Kinaxo Biotechnologies GmbH, a Munich-based drug discovery alliance company supporting the development of targeted drugs.

9 Feb 2011

PBNC technology may help detect cardiac disease, reduce diagnostic costs

Heart disease is a silent killer, but new microchip technology from Rice University is expected to advance the art of diagnosis.

9 Feb 2011

Study: E-cigarettes are safer alternative to tobacco smoking

A study just released by the Journal of Public Health Policy is taking a closer look at traditional tobacco cigarettes vs. e-cigarettes, and the results are surprising even the biggest skeptics. Based on available evidence, the study "Electronic cigarettes as a harm reduction strategy for tobacco control: A step forward or a repeat of past mistakes?" concluded that e-cigarettes are safer than tobacco cigarettes, and have the potential to become a smoking cessation device.

9 Feb 2011

No effort for ensuring continuity of supports and services as ASD children age into adulthood: Study

What happens to young adults with autism spectrum disorders (ASDs) once they graduate high school and are no longer entitled to services?

9 Feb 2011

IDF commends Illinois advisory committee for unanimous vote to recommend SCID Newborn Screening

The Illinois Genetic and Metabolic Diseases Advisory Committee voted unanimously to recommend that the Department of Health screen all newborns for Severe Combined Immune Deficiency (SCID) - commonly known as bubble boy disease.

9 Feb 2011

Over 45 telemedicine networks under management of InTouch Health

InTouch Health® today announced that more than 45 telemedicine networks are currently under management. In total, these networks represent 475 contracted hospital locations where 375 are delivering telemedicine clinical services and the remaining 100 are undergoing pre-installation planning. InTouch Health provides complete telemedicine solutions that allow physicians to remotely perform real-time consults with hospital patients.

9 Feb 2011

East Texas Medical Center implements Unibased Consumer Access and Scheduling for Healthcare patient portal

Unibased Systems Architecture (Unibased), delivering market-leading enterprise scheduling and surgery management solutions to improve access and coordination of care, announced today that East Texas Medical Center (ETMC) has implemented the Unibased patient portal, Consumer Access and Scheduling for Healthcare (CASH).

9 Feb 2011

d-Wise launches innovative, web-based search platform for clinical data systems

d-Wise, provider of powerful business solutions for the unique challenges of the Life Sciences & Healthcare industries, has introduced Reveal, an innovative, web-based search platform that quickly returns results across multiple clinical data systems.

9 Feb 2011

NCCN praises Aetna for evidence-based approach to treat cancer

The National Comprehensive Cancer Network® (NCCN) has praised Aetna for its evidence-based approach to drugs used to treat cancer. The NCCN also acknowledged Aetna's commitment to providing health benefits to members enrolled in clinical trials. Aetna is the first national health plan to be recognized by the group.

9 Feb 2011

Zogenix receives 2011 DDP Industry Achievement Award for SUMAVEL DosePro

Zogenix, Inc. today announced that it has received the 2011 Drug Delivery Partnerships™ ("DDP") Innovation Award in the Industry Achievement category for SUMAVEL DosePro (sumatriptan injection) Needle-free Delivery System.

9 Feb 2011

Protect Pharma completes sale of two patents and patents-applications to Grunenthal

Protect Pharmaceutical Corporation announced that it has completed the sale of two patents and patents-applications to Grunenthal GmbH, a German specialty pharmaceutical company that is a pioneer in pain drug discovery and research. The patent portfolio includes innovative pain drugs that address the large and underserved pain market.

9 Feb 2011

Clinical Data reports $2.0 million revenue for third quarter 2011

Clinical Data, Inc. today announced operational and financial results for the third fiscal quarter ended December 31, 2010. The Company received approval from the U.S. Food and Drug Administration (FDA) of Viibryd™ for the treatment of adults with major depressive disorder (MDD) on January 21, 2011.

9 Feb 2011

PolyMedix commences PMX-60056 Phase 2 clinical trial in patients undergoing PCI

PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat infectious diseases and acute cardiovascular disorders, has initiated a Phase 2 clinical trial, following conclusion of a review by the United States Food and Drug Administration (FDA) of a protocol submitted by PolyMedix, to assess the safety and efficacy of its heptagonist, PMX-60056, in reversing heparin in patients undergoing Percutaneous Coronary Intervention (PCI) procedures.

9 Feb 2011

Repligen third quarter total revenue increases 26% to $7,068,000

Repligen Corporation today reported results for the third quarter of fiscal year 2011, ended December 31, 2010. Total revenue for the quarter was $7,068,000 compared to total revenue of $5,617,000 for the third quarter of fiscal year 2010 ended December 31, 2009, an increase of $1,451,000 or 26%.

9 Feb 2011

GeoVax opens second HIV clinical trial site at Alabama Vaccine Research Clinic

GeoVax Labs, Inc., a biotechnology company that creates, develops and tests innovative HIV/AIDS vaccines, announced today the opening of a second clinical trial site at the Alabama Vaccine Research Clinic (AVRC) of the University of Alabama at Birmingham (UAB) to expand the company's HIV therapeutic vaccine trial.

9 Feb 2011